Business
Zefiro Founder and Former Chairman Updates Shareholders on Recent Developments at the Company
Board has been focused on entrenchment and positive spin while delaying the opportunity for shareholders to vote on Company’s futureTORONTO, Dec. 16, 2025 (GLOBE NEWSWIRE) -- Dr. Talal A. Debs, Founder and Director of Zefiro Methane Corp. (Cboe: ZEFI) ("Zefiro" or the “Company”), today provided an update to shareholders on recent developments at the Company. (All dollar figures are stated in Canadian dollars unless otherwise noted.) “The board of directors at Zefiro (the “Board”) has made much o
About this update from Zefiro Methane Corp.
[{"type":"text","content":"Board has been focused on entrenchment and positive spin while delaying the opportunity for shareholders to vote on Company’s future","length":132,"tagName":"p"},{"type":"text","content":"TORONTO, Dec. 16, 2025 (GLOBE NEWSWIRE) -- Dr. Talal A. Debs, Founder and Director of Zefiro Methane Corp. (Cboe: ZEFI) ("Zefiro" or the “Company”), today provided an update to shareholders on recent developments at the Company. (All dollar figures are stated in Canadian dollars unless otherwise noted.)","length":314,"tagName":"p"},{"type":"text","content":"“The board of directors at Zefiro (the “Board”) has made much of recent positive news, the groundwork for which was largely laid by the former Zefiro leadership team. While I always welcome good news, recent filings detail actions that appear to be an attempt at ‘entrenching’ current management at the expense of Zefiro shareholders. These include enhancing executive compensation (including by providing certain executives with golden parachutes), diluting shareholders with share issuances as a result of debt settlements, and patterns of insider purchases that may be intended to present a broader sense of shareholder approval than is really the case; all of these actions appear intended to improve the Board’s own position in the face of an upcoming proxy contest,” said Dr. Debs. “Meanwhile, the Board has been denying shareholders the opportunity to vote on the future of their own company by failing to hold an annual meeting in 2025 as required by law and delaying the meeting until March 4, 2026 (the “Meeting”). I continue to believe Zefiro shareholders deserve much better.”","length":1088,"tagName":"p"},{"type":"text","content":"In the interest of keeping the Company’s shareholders well informed, Dr. Debs has established a website at www.zefirotruth.com. The website includes details on the highly qualified directors that Dr. Debs intends to nominate for election to the board of directors at the Meeting and will be updated with additional information relating to Zefiro in the coming months.","length":367,"tagName":"p"},{"type":"text","content":"Insider purchases may have distorted the share price","length":52,"tagName":"p"},{"type":"text","content":"The Company issued a news release on December 1, 2025 to announce the recent purchase of 723,000 shares by four Board members. It appears...